Millennium Capital Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Millennium Capital Advisors's PFE Position: Q2 2026 in Review
Millennium Capital Advisors increased its Pfizer (PFE) stake by 20% in Q2 2026, buying an estimated $237K and bringing the position to 53,877 shares worth $1.3M. The position accounts for 0.71% of the portfolio, ranked #30.
Millennium Capital Advisors first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.71M in Q4 2021. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Millennium Capital Advisors held 53,877 shares of Pfizer worth $1.3M as of Q2 2026.
- Millennium Capital Advisors bought 9,042 Pfizer shares in Q2 2026, an estimated $237K.
- Pfizer made up 0.71% of Millennium Capital Advisors's portfolio in Q2 2026, its #30 holding.
- Millennium Capital Advisors first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Millennium Capital Advisors's Pfizer position peaked at $2.71M in Q4 2021.
- 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Millennium Capital Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.